Aerie Pharmaceuticals, Inc. (AERI) At $54.30 Forms Top; Standard Motor Products Has 1.98 Sentiment

Aerie Pharmaceuticals, Inc. (AERI) formed multiple top with $57.02 target or 5.00% above today’s $54.30 share price. Aerie Pharmaceuticals, Inc. (AERI) has $2.13B valuation. The stock decreased 4.82% or $2.75 during the last trading session, reaching $54.3. About 461,343 shares traded or 27.00% up from the average. Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has risen 180.20% since February 6, 2017 and is uptrending. It has outperformed by 163.50% the S&P500.

Standard Motor Products, Inc. manufactures and distributes replacement parts for motor vehicles in the automotive aftermarket industry. The company has market cap of $1.05 billion. The companyÂ’s Engine Management segment makes engine management replacement parts, including electronic ignition control modules, fuel injectors, remanufactured diesel injectors and pumps, ignition wires, coils, switches, sensors, relays, EGR valves, distributor caps and rotors, electronic throttle bodies, and other engine management components, as well as wire and cable parts. It has a 19.63 P/E ratio. It offers its products primarily under the Standard, Blue Streak, BWD, Select, Intermotor, OEM, LockSmart, TechSmart, Tech Expert, and GP Sorensen brands, as well as through private labels, such as CARQUEST, Duralast, Duralast Gold, Import Direct, Master Pro, NAPA Echlin, NAPA Proformer, Mileage Plus, NAPA Belden, Omni-Spark, Ultima Select, and Driveworks.

Among 15 analysts covering Aerie Pharmaceuticals (NASDAQ:AERI), 15 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Aerie Pharmaceuticals had 46 analyst reports since August 7, 2015 according to SRatingsIntel. The stock has “Buy” rating by Cowen & Co on Thursday, November 9. As per Thursday, July 27, the company rating was maintained by Stifel Nicolaus. The stock of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) has “Buy” rating given on Tuesday, November 1 by Aegis Capital. The firm has “Buy” rating given on Wednesday, September 6 by Mizuho. The firm earned “Buy” rating on Thursday, July 20 by H.C. Wainwright. Cantor Fitzgerald maintained the stock with “Buy” rating in Monday, December 18 report. The stock of Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) earned “Buy” rating by Stifel Nicolaus on Thursday, September 17. The firm has “Buy” rating given on Tuesday, September 26 by Cowen & Co. RBC Capital Markets maintained Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) rating on Thursday, September 15. RBC Capital Markets has “Outperform” rating and $55 target. As per Monday, October 16, the company rating was maintained by Canaccord Genuity.

Analysts await Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) to report earnings on March, 6. They expect $-1.44 EPS, down 65.52% or $0.57 from last year’s $-0.87 per share. After $-0.89 actual EPS reported by Aerie Pharmaceuticals, Inc. for the previous quarter, Wall Street now forecasts 61.80% negative EPS growth.

Investors sentiment increased to 1.73 in 2017 Q3. Its up 0.56, from 1.17 in 2017Q2. It is positive, as 14 investors sold Aerie Pharmaceuticals, Inc. shares while 41 reduced holdings. 26 funds opened positions while 69 raised stakes. 34.42 million shares or 8.89% more from 31.61 million shares in 2017Q2 were reported. 24,898 were reported by Manufacturers Life Insur The. Credit Suisse Ag holds 116,789 shares. Ny State Common Retirement Fund accumulated 37,651 shares or 0% of the stock. Sei Investments holds 0% or 3,105 shares. Tradewinds Capital Mgmt holds 0% or 185 shares. Cranbrook Wealth Mngmt Ltd Liability Corp holds 0.01% of its portfolio in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 500 shares. Foresite Management Ii Ltd Com reported 1.67 million shares. Broadfin Cap Llc has invested 0.47% of its portfolio in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI). Macquarie Grp Inc Limited owns 30,760 shares. Colony Gru Ltd Limited Liability Company owns 0.02% invested in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 5,370 shares. Voya Investment Mngmt Limited Liability, a Georgia-based fund reported 501,741 shares. Northern Corp holds 0.01% or 426,036 shares in its portfolio. 6,444 were accumulated by Gsa Cap Ptnrs Limited Liability Partnership. C Ww Wide Gru A S owns 89,384 shares. Invesco Ltd owns 0.01% invested in Aerie Pharmaceuticals, Inc. (NASDAQ:AERI) for 407,068 shares.

Since January 1, 0001, it had 0 insider buys, and 20 insider sales for $3.77 million activity.

The stock decreased 3.09% or $1.48 during the last trading session, reaching $46.37. About 151,743 shares traded or 47.71% up from the average. Standard Motor Products, Inc. (SMP) has risen 32.15% since February 6, 2017 and is uptrending. It has outperformed by 15.45% the S&P500.

Analysts await Standard Motor Products, Inc. (NYSE:SMP) to report earnings on February, 15. They expect $0.39 EPS, down 7.14% or $0.03 from last year’s $0.42 per share. SMP’s profit will be $8.82 million for 29.72 P/E if the $0.39 EPS becomes a reality. After $0.74 actual EPS reported by Standard Motor Products, Inc. for the previous quarter, Wall Street now forecasts -47.30% negative EPS growth.